Enovis Corporation (ENOV)
NYSE · Healthcare
Enovis Corporation Shareholder Equity 2009–2025
Enovis Corporation annual shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Enovis Corporation shareholder equity as of December 31, 2025: 1.49B, a 41.86% decrease year-over-year.
- Enovis Corporation shareholder equity for 2025 were 1.49B, a 41.86% decrease from 2024.
- Enovis Corporation shareholder equity for 2024 were 2.56B, a 25.04% decrease from 2023.
- Enovis Corporation shareholder equity for 2023 were 3.42B, a 0.86% decrease from 2022.
- Enovis Corporation shareholder equity for 2022 were 3.45B.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Enovis Corporation Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $1,490 |
| 2024 | $2,562 |
| 2023 | $3,418 |
| 2022 | $3,448 |
| 2021 | $4,617 |
| 2020 | $3,543 |
| 2019 | $3,441 |
| 2018 | $3,270 |
| 2017 | $3,500 |
| 2016 | $2,897 |
| 2015 | $3,070 |
| 2014 | $3,147 |
| 2013 | $2,514 |
| 2012 | $1,912 |
| 2011 | $189 |
Enovis Corporation Shareholder Equity — FAQ
Enovis Corporation (ENOV) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ENOV's shareholder equity history?
The chart and table above show Enovis Corporation's shareholder equity by year and by quarter, including the growth rate.